
Bonesupport Holding AB
STO:BONEX

Bonesupport Holding AB?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
245
400.2
|
Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Bonesupport Holding AB hold over its rivals?
What risks and challenges
does Bonesupport Holding AB face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Bonesupport Holding AB.
Provide an overview of the primary business activities
of Bonesupport Holding AB.
What unique competitive advantages
does Bonesupport Holding AB hold over its rivals?
What risks and challenges
does Bonesupport Holding AB face in the near future?
Has there been any significant insider trading activity
in Bonesupport Holding AB recently?
Summarize the latest earnings call
of Bonesupport Holding AB.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Bonesupport Holding AB.
Provide P/S
for Bonesupport Holding AB.
Provide P/E
for Bonesupport Holding AB.
Provide P/OCF
for Bonesupport Holding AB.
Provide P/FCFE
for Bonesupport Holding AB.
Provide P/B
for Bonesupport Holding AB.
Provide EV/S
for Bonesupport Holding AB.
Provide EV/GP
for Bonesupport Holding AB.
Provide EV/EBITDA
for Bonesupport Holding AB.
Provide EV/EBIT
for Bonesupport Holding AB.
Provide EV/OCF
for Bonesupport Holding AB.
Provide EV/FCFF
for Bonesupport Holding AB.
Provide EV/IC
for Bonesupport Holding AB.
Show me price targets
for Bonesupport Holding AB made by professional analysts.
What are the Revenue projections
for Bonesupport Holding AB?
How accurate were the past Revenue estimates
for Bonesupport Holding AB?
What are the Net Income projections
for Bonesupport Holding AB?
How accurate were the past Net Income estimates
for Bonesupport Holding AB?
What are the EPS projections
for Bonesupport Holding AB?
How accurate were the past EPS estimates
for Bonesupport Holding AB?
What are the EBIT projections
for Bonesupport Holding AB?
How accurate were the past EBIT estimates
for Bonesupport Holding AB?
Compare the revenue forecasts
for Bonesupport Holding AB with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Bonesupport Holding AB and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Bonesupport Holding AB against its competitors.
Analyze the profit margins
(gross, operating, and net) of Bonesupport Holding AB compared to its peers.
Compare the P/E ratios
of Bonesupport Holding AB against its peers.
Discuss the investment returns and shareholder value creation
comparing Bonesupport Holding AB with its peers.
Analyze the financial leverage
of Bonesupport Holding AB compared to its main competitors.
Show all profitability ratios
for Bonesupport Holding AB.
Provide ROE
for Bonesupport Holding AB.
Provide ROA
for Bonesupport Holding AB.
Provide ROIC
for Bonesupport Holding AB.
Provide ROCE
for Bonesupport Holding AB.
Provide Gross Margin
for Bonesupport Holding AB.
Provide Operating Margin
for Bonesupport Holding AB.
Provide Net Margin
for Bonesupport Holding AB.
Provide FCF Margin
for Bonesupport Holding AB.
Show all solvency ratios
for Bonesupport Holding AB.
Provide D/E Ratio
for Bonesupport Holding AB.
Provide D/A Ratio
for Bonesupport Holding AB.
Provide Interest Coverage Ratio
for Bonesupport Holding AB.
Provide Altman Z-Score Ratio
for Bonesupport Holding AB.
Provide Quick Ratio
for Bonesupport Holding AB.
Provide Current Ratio
for Bonesupport Holding AB.
Provide Cash Ratio
for Bonesupport Holding AB.
What is the historical Revenue growth
over the last 5 years for Bonesupport Holding AB?
What is the historical Net Income growth
over the last 5 years for Bonesupport Holding AB?
What is the current Free Cash Flow
of Bonesupport Holding AB?
Discuss the annual earnings per share (EPS)
trend over the past five years for Bonesupport Holding AB.
EV/EBIT
Enterprise Value to EBIT
Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.
Market Cap | EV/EBIT | ||||
---|---|---|---|---|---|
SE |
![]() |
Bonesupport Holding AB
STO:BONEX
|
17B SEK | 102.1 | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
6T USD | -199 584.9 |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
325.2B USD | 22.1 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
150.6B USD | 22.7 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
134.5B USD | 13.6 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
114.7B USD | 25.8 |
|
US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | -544.7 |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
119.7B AUD | 21.7 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
64.9B USD | 14.6 |
|
US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | -57.8 |
|
US |
![]() |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
37.8B USD | -313.6 |
|
EBIT Growth | EV/EBIT to Growth | |||||
---|---|---|---|---|---|---|
SE |
![]() |
Bonesupport Holding AB
STO:BONEX
|
Average EV/EBIT:
31.8
102.1
|
123%
|
0.8 | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
Negative Multiple: -199 584.9 | N/A | N/A |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
22.1
|
29%
|
0.8 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
22.7
|
31%
|
0.7 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
13.6
|
11%
|
1.2 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
25.8
|
17%
|
1.5 |
|
US |
E
|
Epizyme Inc
F:EPE
|
Negative Multiple: -544.7 | N/A | N/A |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
21.7
|
14%
|
1.5 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
14.6
|
13%
|
1.1 |
|
US |
S
|
Seagen Inc
F:SGT
|
Negative Multiple: -57.8 | N/A | N/A |
|
US |
![]() |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
Negative Multiple: -313.6 | N/A | N/A |
|
EV/EBIT Forward Multiples
Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.